Choline Theophyllinate PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
4499-40-5
Molecular formula
C12H21N5O3
Molecular weight
283.33 g/mol
Drug class
Theophylline salt complexmethylxanthine bronchodilator
Mechanism of action
Dissociates to release theophylline, which produces bronchodilation mainly through non-selective phosphodiesterase inhibition and adenosine-receptor antagonism, increasing intracellular cyclic AMP in bronchial smooth muscle. Choline is a counter-ion and does not confer a separate therapeutic mechanism.
Indications / reported uses
Historically used for bronchodilation in asthma and reversible obstructive airway disease in countries where products remain authorised; current use is limited by the narrow therapeutic index of theophylline and availability of safer alternatives
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Choline Theophyllinate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Choline Theophyllinate Permitted Daily Exposure (PDE) report (the Choline Theophyllinate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Choline Theophyllinate Occupational Exposure Limit (OEL) report (the Choline Theophyllinate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.